The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling

Identification of RIP1 kinase as a specific cellular target of necrostatins

Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · see citing works

TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways

Hsu, H., Shu, H., Pan, M., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998 · see citing works

TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex

Hsu, H., Huang, J., Shu, H.-B., Baichwal, V., & Goeddel, D. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80252-6 · Cited by 1,182 · see citing works

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J. P., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,102 · see citing works

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

Rothe, M., Wong, S. C., Henzel, W. J., & Goeddel, D. V. (1994) · Cell · doi:10.1016/0092-8674(94)90532-0 · Cited by 1,054 · see citing works

Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMO

Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 998 · see citing works

Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma

Uren (2000) · Molecular Cell · Cited by 971 · see citing works

Linear ubiquitination prevents inflammation and regulates immune signalling

Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940 · see citing works

Circuitry of nuclear factor κB signaling

Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907 · see citing works

TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains

Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A. A., Chiu, Y., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 890 · see citing works

Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2

Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J. C., Strub, G. M., Kim, E. Y., Maceyka, M. W., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 754 · see citing works

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

Dierlamm, J., Baens, M., Włodarska, I., Stefanova-Ouzounova, M., Hernández‐Rivas, J. M., HOSSFELD, D. K., Wolf‐Peeters, C. D., Hagemeijer, A., BERGHE, H. V. D., & Marynen, P. (1999) · Blood · doi:10.1182/blood.v93.11.3601 · Cited by 718 · see citing works

The TRAF6 Ubiquitin Ligase and TAK1 Kinase Mediate IKK Activation by BCL10 and MALT1 in T Lymphocytes

Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 700 · see citing works

Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types

Willis, T. G., Jadayel, D. M., Du, M., Peng, H., Perry, A. R., Abdul-Rauf, M., Price, H. P., Karran, L., Majekodunmi, O., Włodarska, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80957-5 · Cited by 658 · see citing works

Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes

Shembade, N., Ma, A. I., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 644 · see citing works

Identification of Paracaspases and Metacaspases Two Ancient Families of Caspase-like Proteins, One of which Plays a Key Role in MALT Lymphoma

Uren, A. G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00094-0 · Cited by 638 · see citing works

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation

Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 607 · see citing works

c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation

Varfolomeev, E. E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J., & Vucic, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800128200 · Cited by 554 · see citing works

RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis.

Ting, A. T., Pimentel‐Muiños, F. X., & Seed, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01007.x · Cited by 550 · see citing works

Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

Zhou, H., Wertz, I. E., O’Rourke, K. M., Ultsch, M. H., Seshagiri, S., Eby, M. T., Xiao, W., & Dixit, V. M. (2003) · Nature · doi:10.1038/nature02273 · Cited by 527 · see citing works

MALT lymphoma: from morphology to molecules

Isaacson, P. G., & Du, M. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1409 · Cited by 522 · see citing works

A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation

Hasegawa, M., Fujimoto, Y., Lucas, P. C., Nakano, H., Fukase, K., Núñez, G., & Inohara, N. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601962 · Cited by 520 · see citing works

T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma

Streubel, B., Lamprecht, A., Dierlamm, J., Cerroni, L., Stolte, M., Ott, G., Raderer, M., & Chott, A. (2003) · Blood · doi:10.1182/blood-2002-09-2963 · Cited by 493 · see citing works

T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20

Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 437 · see citing works

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

Liu, H., Ye, H., Ruskone-Fourmestraux, A., de Jong, D., Pileri, S. A., Thiede, C., Lavergne‐Slove, A., Boot, H., Caletti, G., Wündisch, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33047 · Cited by 420 · see citing works

Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway

Lucas, P. C., Yonezumi, M., Inohara, N., McAllister‐Lucas, L. M., Abazeed, M. E., Chen, F. F., Yamaoka, S., Seto, M., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009984200 · Cited by 417 · see citing works

TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway

Takaesu, G., Surabhi, R. M., Park, K.-J., Ninomiya‐Tsuji, J., Matsumoto, K., & Gaynor, R. B. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01404-3 · Cited by 404 · see citing works

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

Zhang, Q., Siebert, R., Yan, M., Hinzmann, B., Cui, X., Xue, L., Rakestraw, K. M., Naeve, C. W., Beckmann, G., Weisenburger, D. D., et al. (1999) · Nature Genetics · doi:10.1038/8767 · Cited by 374 · see citing works

A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue

Akagi, T., Motegi, M., Tamura, A., Suzuki, R., Hosokawa, Y., Suzuki, H., Ota, H., Nakamura, S., Morishima, Y., Taniwaki, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1203018 · Cited by 346 · see citing works

Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling

O'Donnell, M. A., Legarda-Addison, D., Skountzos, P., Yeh, W. C., & Ting, A. T. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.027 · Cited by 310 · see citing works

Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation

Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277 · see citing works

NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling

Biton, S., & Ashkenazi, A. (2011) · Cell · doi:10.1016/j.cell.2011.02.023 · Cited by 262 · see citing works

The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2

Lee, T. H.-Y., Shank, J., Cusson, N., & Kelliher, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404206200 · Cited by 255 · see citing works

T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10

Liu, H., Ye, H., Doǧan, A., Ranaldi, R., Hamoudi, R., Bearzi, I., Isaacson, P. G., & Du, M. (2001) · Blood · doi:10.1182/blood.v98.4.1182 · Cited by 245 · see citing works

TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis

Vince, J. E., Pantaki-Eimany, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W.-L., Gentle, I. E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072256 · Cited by 241 · see citing works

Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1Preprint

Thome, M., Charton, J. E., Pelzer, C., & Hailfinger, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003004 · Cited by 241 · see citing works

T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1

Staal, J., Driege, Y., Bekaert, T., Demeyer, A., Muyllaert, D., Damme, P. V., Gevaert, K., & Beyaert, R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.85 · Cited by 221 · see citing works

Malt1 ubiquitination triggers NF‐κB signaling upon T‐cell activation

Oeckinghaus, A., Wegener, E., Welteke, V., Ferch, U., Arslan, S. Ç., Ruland, J., Scheidereit, C., & Krappmann, D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601897 · Cited by 208 · see citing works

SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP

Lü, J., Bai, L., Sun, H., Nikolovska‐Coleska, Z., McEachern, D., Qiu, S., Miller, R. S., Han, Y., Shangary, S. K., Sun, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2655 · Cited by 200 · see citing works

Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18.

Morgan, J. A., Yin, Y., Borowsky, A. D., Kuo, F. C., Nourmand, N., Koontz, J. I., Reynolds, C., Soreng, L., Griffin, C. A., Graeme‐Cook, F., et al. (1999) · PubMed · Cited by 171 · see citing works

Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation

Rosebeck, S., Madden, L. M., Jin, X., Gu, S., Apel, I. J., Appert, A., Hamoudi, R., Noels, H., Sagaert, X., Loo, P. V., et al. (2011) · Science · doi:10.1126/science.1198946 · Cited by 158 · see citing works

A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage

Yang, Y., Xia, F., Hermance, N. M., Mabb, A. M., Simonson, S. J. S., Morrissey, S., Gandhi, P., Munson, M., Miyamoto, S., & Kelliher, M. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01139-10 · Cited by 140 · see citing works

Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity

Zhou, H., Du, M., & Dixit, V. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.012 · Cited by 140 · see citing works

A20 Ubiquitin Ligase–Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma

Bellail, A. C., Olson, J. J., Yang, X., Chen, Z. J., & Hao, C. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0172 · Cited by 113 · see citing works

Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2

Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 112 · see citing works

A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-κB Activation by API2·MALT1 Fusions

Noels, H., Loo, G., Hagens, S., Broeckx, V., Beyaert, R., Marynen, P., & Baens, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611038200 · Cited by 88 · see citing works

Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination

Baens, M., Fevery, S., Sagaert, X., Noels, H., Hagens, S., Broeckx, V., Billiau, A., Wolf‐Peeters, C. D., & Marynen, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4590 · Cited by 70 · see citing works

A Protective Strategy against Hyperinflammatory Responses Requiring the Nontranscriptional Actions of GPS2

Cardamone, M. D., Krones, A., Tanasă, B., Taylor, H., Ricci, L., Ohgi, K. A., Glass, C. K., Rosenfeld, M. G., & Perissi, V. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.025 · Cited by 69 · see citing works

Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis

Stoffel, A., Chaurushiya, M. S., Singh, B., & Levine, A. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402415101 · Cited by 56 · see citing works

Non-Canonical NF-κB Activation and Abnormal B Cell Accumulation in Mice Expressing Ubiquitin Protein Ligase-Inactive c-IAP2

Conze, D. B., Zhao, Y., & Ashwell, J. D. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000518 · Cited by 54 · see citing works

A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation: heterotypic oligomerization and TRAF2 recruitment

Lucas, P. C., Kuffa, P., Gu, S., Kohrt, D., Kim, D. S. L., Siu, K., Jin, X., Swenson, J., & McAllister‐Lucas, L. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210342 · Cited by 53 · see citing works

Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis

Duprez, L., Bertrand, M. J. M., Berghe, T. V., Dondelinger, Y., Festjens, N., & Vandenabeele, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288670 · Cited by 46 · see citing works

TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-κB

Garrison, J. B., Samuel, T., & Reed, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.17 · Cited by 33 · see citing works

Tumor Necrosis Factor Receptor-associated Factor Family Protein 2 Is a Key Mediator of the Epidermal Growth Factor-induced Ribosomal S6 Kinase 2/cAMP-responsive Element-binding Protein/Fos Protein Signaling Pathway

Peng, C., Zhu, F., Wen, W., Yao, K., Li, S., Zykova, T. A., Liu, K., Li, X., Ma, W., Bode, A. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359521 · Cited by 18 · see citing works

Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies

Nagel, D., Vincendeau, M., Eitelhuber, A. C., & Krappmann, D. (2014) · Oncogene · doi:10.1038/onc.2013.565 · Cited by 129 · see citing works

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126 · see citing works

NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms

Yu, L., Li, L., Medeiros, L. J., & Young, K. H. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.10.001 · Cited by 105 · see citing works

Helicobacter pylori -negative gastric mucosa-associated lymphoid tissue lymphomas: A review

Asano, N. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i26.8014 · Cited by 81 · see citing works

Cortistatin binds to TNF-α receptors and protects against osteoarthritis

Zhao, Y., Li, Y., Qu, R., Chen, X., Wang, W., Qiu, C., Liu, B., Pan, X. L., Liu, L., Vasilev, K. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.035 · Cited by 72 · see citing works

IAP-Mediated Protein Ubiquitination in Regulating Cell Signaling

Dumétier, B., Zadoroznyj, A., & Dubrez, L. (2020) · Cells · doi:10.3390/cells9051118 · Cited by 60 · see citing works

p62/ SQSTM 1 as an oncotarget mediates cisplatin resistance through activating RIP 1‐ NF ‐κB pathway in human ovarian cancer cells

Yan, X., Zhang, Y., Zhang, J., Zhang, L., Liu, Y., Wu, Y., Xue, Y., Lu, S., Su, J., & Sun, L. (2017) · Cancer Science · doi:10.1111/cas.13276 · Cited by 59 · see citing works

The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling

Vera‐Otarola, J., Solís, L., Lowy, F., Olguín, V., Angulo, J., Pino, K., Tischler, N. D., Carola Otth, L., Padula, P., & López‐Lastra, M. (2020) · Journal of Virology · doi:10.1128/jvi.00454-20 · Cited by 45 · see citing works

MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies

Liang, X., Cao, Y.-C., Li, C., Yu, H., Yang, C., & Liu, H. S. (2021) · Medicinal Research Reviews · doi:10.1002/med.21799 · Cited by 34 · see citing works

Targeting the TNF-α–TNFR interaction with EGCG to block NF-κB signaling in human synovial fibroblasts

Xu, H., Gan, C., Xiang, Z., Xiang, T., Li, J., Huang, X., Qin, X., Liu, T., Sheng, J., & Wang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114575 · Cited by 32 · see citing works

Andrographolide attenuates synovial inflammation of osteoarthritis by interacting with tumor necrosis factor receptor 2 trafficking in a rat model

Wang, R., Li, J., Xu, X., Xu, J. L., Jiang, H., Lv, Z., Wu, R., Sun, Z., Guo, W., Sun, Y., et al. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.05.001 · Cited by 28 · see citing works

Mechanisms of NF-κB deregulation in lymphoid malignancies

Krappmann, D., & Vincendeau, M. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.05.002 · Cited by 26 · see citing works

Radical surgery may be not an optimal treatment approach for pulmonary MALT lymphoma

Wang, L., Xia, Z.-J., Zhang, Y.-J., Huang, H.-Q., Lin, T.-Y., & Lu, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3329-y · Cited by 22 · see citing works

Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results

Toyoda, K., Maeshima, A. M., Nomoto, J., Suzuki, T., Yuda, S., Yamauchi, N., Taniguchi, H., Makita, S., Fukuhara, S., Munakata, W., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03671-5 · Cited by 21 · see citing works

GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein

Cheng, J., Klei, L. R., Hubel, N. E., Zhang, M., Schairer, R., Maurer, L. M., Klei, H. B., Kang, H., Concel, V. J., Delekta, P. C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci97040 · Cited by 19 · see citing works

EMZL at various sites: learning from each other

Du, M. (2025) · Blood · doi:10.1182/blood.2024025794 · Cited by 17 · see citing works

Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases

Zhang, Y., Peng, J., & Luo, X. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114977 · Cited by 16 · see citing works

Unexpected functions of nuclear factor-κB during germinal center B-cell development

Klein, U., & Heise, N. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000160 · Cited by 16 · see citing works

Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis

Wang, X., Cheng, D., Hu, G., Liang, L., Tan, F., Xiao, T., Xiao, S., & Xia, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/2945083 · Cited by 15 · see citing works

API2-MALT1 oncoprotein promotes lymphomagenesisviaunique program of substrate ubiquitination and proteolysis

Rosebeck, S. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.128 · Cited by 10 · see citing works

B(a)P induces ovarian granulosa cell apoptosis via TRAF2-NFκB-Caspase1 axis during early pregnancy.

Xu, H., Chen, F.-Y., Liu, Z., Gao, R.-F., He, J.-L., Li, F.-F., Li, N., Mu, X.-Y., Liu, T.-H., Wang, Y.-X., et al. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118865 · Cited by 8 · see citing works

RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression

Quarni, W., Lungchukiet, P., Tse, A. K., Wang, P., Sun, Y., Kasiappan, R., Wu, J.-Y., Zhang, X. M., & Bai, W. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.024 · Cited by 7 · see citing works

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from (auto)antigen driven selection to the activation of NF-κB signaling

Zhang, Y., Wei, Z., Li, J., & Liu, P. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4977-2 · Cited by 6 · see citing works

Targeting paracaspase1 (MALT1) for cancer therapy: Updated progress and study on structure-activity relationships (SARs)

Li, Y., Hong, Y., Zhang, J., & Xu, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118372 · Cited by 5 · see citing works

MALT1 Paracaspase: A Unique Protease Involved in B-Cell Lymphomagenesis

Vincendeau, M., Nagel, D., Eitelhuber, A. C., & Krappmann, D. (2013) · International Journal of Hematologic Oncology · doi:10.2217/ijh.13.45 · Cited by 2 · see citing works

Squamous cell lung cancer coexisting with pulmonary MALT lymphoma: a rare case reportPreprint

Li, A., Jiang, L., Hu, Y., Liu, Z., & Jiang, B. (2024) · Research Square · doi:10.21203/rs.3.rs-5295067/v1

Cross-tissue atlas of mucosa-associated lymphoid tissue lymphomas reveals intratumoral heterogeneity and microenvironmental subtypes

Kang, K., Wu, Y., Sun, X., Yang, Y., Liang, W., Yang, J., Tang, Y., Xiang, B., Niu, T., & Zhao, A. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102785

API2-MALT1 oncoprotein promotes lymphomagenesisviaunique program of substrate ubiquitination and proteolysis

Rosebeck, S. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.128 · Cited by 10 · see citing works

A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation: heterotypic oligomerization and TRAF2 recruitment

Lucas, P. C., Kuffa, P., Gu, S., Kohrt, D., Kim, D. S. L., Siu, K., Jin, X., Swenson, J., & McAllister‐Lucas, L. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210342 · Cited by 53 · see citing works

A Novel TRAF6 Binding Site in MALT1 Defines Distinct Mechanisms of NF-κB Activation by API2·MALT1 Fusions

Noels, H., Loo, G., Hagens, S., Broeckx, V., Beyaert, R., Marynen, P., & Baens, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611038200 · Cited by 88 · see citing works

Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis

Stoffel, A., Chaurushiya, M. S., Singh, B., & Levine, A. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402415101 · Cited by 56 · see citing works

Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma

Hosokawa, Y. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6059-6 · Cited by 35 · see citing works